Within a key area of ongoing research, IFN-1 represents as a central driver binds to multiple immune cell types activating a signalling that can lead to systemic inflammation, tissue injury, and clinical manifestations in SLE. To better illustrate the relationship between clinical symptoms of SLE and type 1 IFN, there is a video demonstrating the role of Type I IFN in SLE pathophysiology.
Please watch the video and complete a short survey to help us assess the educational outcomes as part of continuing professional development efforts.